294 related articles for article (PubMed ID: 27435395)
21. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
22. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
23. IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer.
Zhao Q; Qian L; Guo Y; Lü J; Li D; Xie H; Wang Q; Ma W; Liu P; Liu Y; Wang T; Wu X; Han J; Yu Z
Theranostics; 2023; 13(7):2337-2349. PubMed ID: 37153732
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer.
Shibuya N; Kakeji Y; Shimono Y
Cancer Sci; 2020 Jun; 111(6):2093-2103. PubMed ID: 32307765
[TBL] [Abstract][Full Text] [Related]
25. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
Sahranavardfard P; Firouzi J; Azimi M; Khosravani P; Heydari R; Emami Razavi A; Dorraj M; Keighobadi F; Ebrahimi M
J Cell Physiol; 2019 Nov; 234(11):20193-20205. PubMed ID: 31016725
[TBL] [Abstract][Full Text] [Related]
27. Endogenous human microRNAs that suppress breast cancer metastasis.
Tavazoie SF; Alarcón C; Oskarsson T; Padua D; Wang Q; Bos PD; Gerald WL; Massagué J
Nature; 2008 Jan; 451(7175):147-52. PubMed ID: 18185580
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
29. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
[TBL] [Abstract][Full Text] [Related]
30. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
31. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
32. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
35. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
Gernapudi R; Yao Y; Zhang Y; Wolfson B; Roy S; Duru N; Eades G; Yang P; Zhou Q
Breast Cancer Res Treat; 2015 Apr; 150(3):685-95. PubMed ID: 25783182
[TBL] [Abstract][Full Text] [Related]
36. Shrimp miRNA suppresses the stemness of human cancer stem cells
Zhang S; Zhang X
FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761
[TBL] [Abstract][Full Text] [Related]
37. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
Hongdan L; Feng L
Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
[TBL] [Abstract][Full Text] [Related]
38. The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells.
Leung HW; Ko CH; Yue GG; Herr I; Lau CB
Cancer Chemother Pharmacol; 2018 Aug; 82(2):185-197. PubMed ID: 29777274
[TBL] [Abstract][Full Text] [Related]
39. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
[TBL] [Abstract][Full Text] [Related]
40. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
